Home/Filings/4/0001209191-20-055716
4//SEC Filing

SANDS ARTHUR T 4

Accession 0001209191-20-055716

CIK 0001549595other

Filed

Oct 22, 8:00 PM ET

Accepted

Oct 23, 5:22 PM ET

Size

5.4 KB

Accession

0001209191-20-055716

Insider Transaction Report

Form 4
Period: 2020-10-21
SANDS ARTHUR T
DirectorPresident, CEO
Transactions
  • Award

    Stock Option (right to buy)

    2020-10-21+804,170804,170 total
    Exercise: $26.91Exp: 2030-10-20Common Stock (804,170 underlying)
Footnotes (1)
  • [F1]The stock option vests as to 1/48 of the total shares monthly beginning August 23, 2020 until the option is fully vested on July 23, 2024, subject to the Reporting Person's provision of service to the Issuer on each vesting date.

Issuer

Nurix Therapeutics, Inc.

CIK 0001549595

Entity typeother

Related Parties

1
  • filerCIK 0001134106

Filing Metadata

Form type
4
Filed
Oct 22, 8:00 PM ET
Accepted
Oct 23, 5:22 PM ET
Size
5.4 KB